Novavax (NVAX)

Company Description

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates.


 

COMPANY ADDRESS
9920 Belward Campus Drive
Rockville, Maryland 20850
United States

COMPANY PHONE
240-268-2000

COMPANY WEBSITE



Get BioInvest's perspective on Novavax's CEO


Latest Company News

Company Stock in Focus: Novavax, Inc. (NASDAQ:NVAX) Sherwood Daily - 5 hours ago Individual investors might be studying multiple metrics in order to maximize returns. Novavax, Inc. (NASDAQ:NVAX) presently has a Gross Margin (Marx) ratio of -0.557153. Novavax, Inc. (NVAX) recently sold by insider YOUNG JAMES F - Post Analyst News Recap: Novavax, Inc. (NASDAQ:NVAX) , FNB Corporation (NYSE:FNB) - NYSE Journal (press release) [...]
Fri, Mar 24, 2017 8:03:00 PM, Continue reading at the source
Market Check: Narrowing in on Shares of Novavax, Inc. (NASDAQ:NVAX) The Standard - 10 hours ago Many investors may be looking to track stock price momentum by looking at different historical information. Novavax, Inc. (NASDAQ:NVAX) currently has a 6 month price index of 0.54043. The six month price index is simply measured by dividing the current ... [...]
Fri, Mar 24, 2017 3:56:00 PM, Continue reading at the source
Novavax, Inc. added 2.42% in its Stock Price in the Previous Trading Session Free Observer - 10 hours ago Currently the shares of Novavax, Inc. (NVAX) has a trading volume of 4.13 Million shares, with an average trading volume of 6.7 Million shares - with shares dropping to a 52 week low of $1.16 on Sep 16, 2016, and the company's shares hitting a 52 week ... Novavax, Inc. (NVAX) Closed the Last Trading Session at $1.27 - The Newburgh Press Checking the Overall Picture for Novavax, Inc. (NVAX) - StockNewsJournal [...]
Fri, Mar 24, 2017 3:11:00 PM, Continue reading at the source
What Do Analysts Suggest For Novavax, Inc. (NVAX) News Oracle - 11 hours ago Novavax, Inc. (NVAX) will report its next earnings on May 2 - May 8 (Est.). The company reported the earnings of $-0.21/Share in the last quarter where the estimated EPS by analysts was $-0.23/share. [...]
Fri, Mar 24, 2017 2:15:00 PM, Continue reading at the source
How much upside really exists in Novavax, Inc. (NVAX) and AbbVie Inc. (ABBV)? USA Commerce Daily - 15 hours ago Shares of Novavax, Inc. (NASDAQ:NVAX) observed rebound of 9.48% since bottoming out at $1.16 on Sep. 16, 2016. Meanwhile, due to an ongoing pressure which caused a decline of almost -7.97% in the past five days, the stock price is now up 0.79% so ... [...]
Fri, Mar 24, 2017 10:31:00 AM, Continue reading at the source
Why Investors remained confident on Novavax, Inc. (NVAX), Abercrombie & Fitch ... StockNewsJournal - Mar 23, 2017 Novavax, Inc. (NVAX) have shown a high EPS growth of -43.40% in the last 5 years and has earnings decline of -72.80% yoy. [...]
Thu, Mar 23, 2017 11:37:00 AM, Continue reading at the source
Novavax Inc. (NVAX) Plunges 7.58% on March 21 Equities.com - Mar 21, 2017 Novavax Inc. (NVAX) had a rough trading day for Tuesday March 21 as shares tumbled 7.58%, or a loss of $-0.1 per share, to close at $1.22. [...]
Tue, Mar 21, 2017 9:30:00 PM, Continue reading at the source
Novavax Inc. (NVAX) Moves Lower on Volume Spike for March 17 Equities.com - Mar 17, 2017 Novavax Inc. (NVAX) traded on unusually high volume on Mar. 17, as the stock lost 2.9% to close at $1.34. On the day, Novavax Inc. saw 17.43 million shares trade hands on 10,876 trades. Considering that the stock averages only a daily volume of 6.4 ... Novavax, Inc. (NVAX) shows optimistic Trends - TopChronicle What Type of Consensus Opinions Analysts hold about Novavax, Inc.'s (NVAX ... - Hot Stocks Point [...]
Fri, Mar 17, 2017 9:30:00 PM, Continue reading at the source
What will save Novavax? A failed drug trial leaves the biotech's fate in question. Washington Business Journal - Mar 17, 2017 Novavax CFO Buck Phillips, left, speaks to Maryland Gov. Larry Hogan, second from right,… more. Courtesy Tom Nappi / Md. governor. [...]
Fri, Mar 17, 2017 9:08:00 AM, Continue reading at the source
Here's Why Novavax, Inc.'s Share Price Went Down the Drain Motley Fool - Feb 28, 2017 Shares of Novavax (NASDAQ:NVAX), a clinical-stage vaccine company focused on developing nanoparticle and recombinant vaccines to treat and prevent a variety of diseases, tanked and fell as much as 11% during Tuesday's trading session, after the ... Novavax, Inc. (NVAX) Announces 4Q and Year-End 2016 Results; Shares Fall - Smarter Analyst Novavax Inc (NASDAQ:NVAX) Could Be A Top Discount Entry Stock - Insider Financial [...]
Tue, Feb 28, 2017 11:13:00 PM, Continue reading at the source